Healthtech Series A Investors & VC Firms
2310 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Passion Capital
LondonPre-Seed–Series A
8 people
Clarendon Fund Managers Ltd.
BelfastPre-Seed–Growth$63K – $3.8M
13 people
Inventure
HelsinkiPre-Seed–Series A$330K – $5.5M
16 people
Motley Fool Ventures
AlexandriaSeed–Series A$1M – $2M
22 people
Visionaries Club
BerlinPre-Seed–Series B$900K
22 people
Alley Robotics Ventures
CohassetPre-Seed–Series A$500K – $2M
3 people
BioGeneration Ventures
NaardenPre-Seed–Late Stage
26 people
VantagePoint Capital Partners
Silicon ValleySeed–Growth$2M – $100M
18 people
DAYLI Partners
SeoulSeed–Late Stage
13 people
Gen Capital
ChicagoPre-Seed–Series A
24 people
T. Rowe Price
BaltimoreSeed–Series C
6 people
XRC
New YorkPre-Seed–Series A$200K – $300K
17 people
Penny Jar Capital Venture
Palo AltoPre-Seed–Series B
33 people
Moonshots Capital
AustinPre-Seed–Series A$5K – $2.5M
10 people
SeaX Ventures
MillbraePre-Seed–Series A$100K – $5M
35 people
META Group
BrusselsSeed–Series A
42 people
Avoro Capital Advisors
New YorkSeries A–Late Stage
22 people
Atomic
San FranciscoPre-Seed–Series A
37 people
coparion
CologneSeed–Growth$550K – $16.5M
26 people
AIF
New YorkSeed–Growth
39 people
Kickfund
BaselSeed–Series A$950K
6 people
Visible Ventures
HinghamPre-Seed–Series A$1M
27 people
venBio Partners
San FranciscoSeed–Series C
10 people
Energy & Environment Investment
TokyoPre-Seed–Growth
18 people
Related lists
Series A Investors & VC Firms (7326)Series A Investors & VC Firms in North America (4220)Healthtech Investors & VC Firms (4191)Series A Investors & VC Firms in United States (3839)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2591)Healthtech Investors & VC Firms in United States (2437)Series A Investors & VC Firms in Europe (2384)
Data sourced from public filings and firms' own websites — see our methodology.




































































































